These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9059686)

  • 1. Chemotherapy-induced acral erythema due to Tegafur.
    Bastida J; Díaz-Cascajo C; Borghi S
    Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686
    [No Abstract]   [Full Text] [Related]  

  • 2. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur.
    Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A
    Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693
    [No Abstract]   [Full Text] [Related]  

  • 3. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
    Jucglà A; Sais G; Navarro M; Peyri J
    Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678
    [No Abstract]   [Full Text] [Related]  

  • 4. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
    Park YJ; Soh BW; Lee ES
    Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
    [No Abstract]   [Full Text] [Related]  

  • 5. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
    Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
    Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
    Ciccolini J; Evrard A; Lacarelle B
    Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908
    [No Abstract]   [Full Text] [Related]  

  • 7. Taxol-induced acral erythema.
    de Argila D; Dominguez JD; Iglesias L
    Dermatology; 1996; 192(4):377-8. PubMed ID: 8864381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Images in clinical medicine. Palmar-plantar rash with cytarabine therapy.
    Rosenbeck L; Kiel PJ
    N Engl J Med; 2011 Jan; 364(3):e5. PubMed ID: 21247311
    [No Abstract]   [Full Text] [Related]  

  • 9. Images in clinical medicine. Chemotherapy-induced acral erythema.
    Pirisi M; Soardo G
    N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
    Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
    Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
    [No Abstract]   [Full Text] [Related]  

  • 11. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
    Tavares-Bello R
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
    [No Abstract]   [Full Text] [Related]  

  • 12. Three cases of chemotherapy-induced acral erythema.
    Komamura H; Higashiyama M; Hashimoto K; Takeda K; Kimura H; Tani Y; Ogawa H; Yoshikawa K
    J Dermatol; 1995 Feb; 22(2):116-21. PubMed ID: 7722086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Painful blistered hands and feet.
    Coyle C; Wenhold V
    Clin J Oncol Nurs; 2001; 5(5):230-2. PubMed ID: 11899771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [6-mercaptopurine-related hand-foot syndrome in a four-year-old child].
    Giacchero D; Monpoux F; Chiavérini C; Lacour JP
    Ann Dermatol Venereol; 2008; 135(8-9):580-3. PubMed ID: 18789293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
    Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis in oncology. Hand-foot syndrome.
    Jucgla A; Sais G
    J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acral erythema occurring after didanosine (Videx) therapy].
    Pedailles S; Launay V; Surbled M; Sentias C; Bazin A
    Ann Dermatol Venereol; 1993; 120(11):837-40. PubMed ID: 8210138
    [No Abstract]   [Full Text] [Related]  

  • 18. Eccrine squamous syringometaplasia in chemotherapy-induced acral erythema.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):284. PubMed ID: 1552086
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose Methotrexate-induced Acral Erythema in Two Pediatric Patients With Acute Lymphoblastic Leukemia: A 17 Pediatric Case Series of Methotrexate-induced Acral Erythema.
    Noguchi K; Nishimura R; Ikawa Y; Mase S; Fujiki T; Kuroda R; Araki R; Maeba H; Yachie A; Wada T
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1259-e1261. PubMed ID: 34486565
    [No Abstract]   [Full Text] [Related]  

  • 20. Tegafur-induced acral hyperpigmentation.
    Llistosella E; Codina A; Alvarez R; Pujol RM; de Moragas JM
    Cutis; 1991 Sep; 48(3):205-7. PubMed ID: 1935249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.